SV2017005586A - Procesos e intermediarios para la preparacion de {1- (etilsulfonil) -3- [4 -(7h -pirrolo [2, 3-d] pirimidin -4- il) -1h -pirazol -1- il] azetidin -3- il} acetonitrilo - Google Patents
Procesos e intermediarios para la preparacion de {1- (etilsulfonil) -3- [4 -(7h -pirrolo [2, 3-d] pirimidin -4- il) -1h -pirazol -1- il] azetidin -3- il} acetonitriloInfo
- Publication number
- SV2017005586A SV2017005586A SV2017005586A SV2017005586A SV2017005586A SV 2017005586 A SV2017005586 A SV 2017005586A SV 2017005586 A SV2017005586 A SV 2017005586A SV 2017005586 A SV2017005586 A SV 2017005586A SV 2017005586 A SV2017005586 A SV 2017005586A
- Authority
- SV
- El Salvador
- Prior art keywords
- etilsulfonil
- pirimidin
- pirrolo
- pirazol
- intermediaries
- Prior art date
Links
- WEVYAHXRMPXWCK-UHFFFAOYSA-N methyl cyanide Natural products CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 title abstract 4
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A PROCESOS E INTERMEDIARIOS PARA LA PREPARACIÓN DE {1 -(ETILSULFONIL)-3-[4-(7H- PIRROLO [2,3-D] PIRIMIDIN-4-IL)-1 H-PIRAZOL-1 -IL]AZETIDIN-3- IL} ACETONITRILO
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562182040P | 2015-06-19 | 2015-06-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
SV2017005586A true SV2017005586A (es) | 2018-04-24 |
Family
ID=56204068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SV2017005586A SV2017005586A (es) | 2015-06-19 | 2017-12-11 | Procesos e intermediarios para la preparacion de {1- (etilsulfonil) -3- [4 -(7h -pirrolo [2, 3-d] pirimidin -4- il) -1h -pirazol -1- il] azetidin -3- il} acetonitrilo |
Country Status (26)
Country | Link |
---|---|
US (2) | US20180134713A1 (es) |
EP (1) | EP3310781A1 (es) |
JP (1) | JP2018519280A (es) |
KR (1) | KR20180008637A (es) |
CN (1) | CN107660206A (es) |
AR (1) | AR104918A1 (es) |
AU (1) | AU2016280815A1 (es) |
BR (1) | BR112017024613A2 (es) |
CA (1) | CA2984627A1 (es) |
CL (1) | CL2017003112A1 (es) |
CO (1) | CO2017013226A2 (es) |
CR (1) | CR20170533A (es) |
DO (1) | DOP2017000300A (es) |
EA (1) | EA201792308A1 (es) |
EC (1) | ECSP17083426A (es) |
HK (1) | HK1248699A1 (es) |
IL (1) | IL255386A0 (es) |
MA (1) | MA45901A (es) |
MX (1) | MX2017015837A (es) |
NZ (1) | NZ736999A (es) |
PE (1) | PE20180504A1 (es) |
PH (1) | PH12017502360A1 (es) |
SV (1) | SV2017005586A (es) |
TN (1) | TN2017000530A1 (es) |
TW (1) | TWI622591B (es) |
WO (1) | WO2016205487A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108341818A (zh) * | 2017-01-21 | 2018-07-31 | 南京华威医药科技开发有限公司 | 巴瑞克替尼及其磷酸盐的新晶型及其制备方法 |
US11524961B2 (en) | 2017-01-23 | 2022-12-13 | Shanghai Longwood Biopharmaceuticals Co., Ltd. | JAK kinase inhibitor and preparation method and use thereof |
CN106946917B (zh) * | 2017-03-20 | 2019-06-11 | 杭州科巢生物科技有限公司 | 一种jak抑制剂巴瑞替尼及其中间体的新合成方法 |
CN107739328B (zh) * | 2017-11-22 | 2020-03-20 | 海化生命(厦门)科技有限公司 | 用于合成巴瑞替尼的关键中间体1的制备方法 |
CN108129482A (zh) * | 2017-12-13 | 2018-06-08 | 江苏中邦制药有限公司 | 一种巴瑞替尼的制备方法 |
US10766900B2 (en) | 2017-12-29 | 2020-09-08 | Formosa Laboratories, Inc. | Baricitinib intermediate, method for forming Baricitinib intermediate, and method for preparing Baricitinib or pharmaceutically acceptable salt thereof |
WO2020072870A1 (en) | 2018-10-05 | 2020-04-09 | Johnson Matthey Public Limited Company | Co-crystal forms of baricitinib |
TW202033198A (zh) | 2018-10-17 | 2020-09-16 | 美商美國禮來大藥廠 | 以巴瑞克替尼(baricitinib)治療原發性膽汁性膽管炎及原發性硬化性膽管炎 |
MX2021012849A (es) | 2019-04-24 | 2022-02-24 | Elanco Us Inc | Una 7-h-pirrolo[2,3-d]pirimidina inhibidora de jak. |
CA3224068A1 (en) | 2021-07-30 | 2023-02-02 | Eli Lilly And Company | Treatment of hand eczema with baricitinib |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5821374A (en) * | 1995-11-21 | 1998-10-13 | Hoffmann-La Roche Inc. | Process for the oxidation of alcohols |
EA017218B1 (ru) * | 2008-03-11 | 2012-10-30 | Инсайт Корпорейшн | Производные азетидина и циклобутана как ингибиторы jak-киназ |
MX2012011941A (es) * | 2010-04-14 | 2013-08-27 | Array Biopharma Inc | Imidazo [1, 2-c] pirimidinas 5, 7-substituidas como inhibidores de jak cinasas. |
CN102557901B (zh) * | 2010-12-15 | 2014-06-11 | 上海医药工业研究院 | 6-氯己醛的制备方法 |
SG10201707259PA (en) * | 2013-03-06 | 2017-10-30 | Incyte Corp | Processes and intermediates for making a jak inhibitor |
CN105541891B (zh) * | 2016-02-04 | 2017-11-28 | 东南大学 | 巴瑞替尼的中间体及其制备方法及由该中间体制备巴瑞替尼的方法 |
-
2016
- 2016-06-06 AR ARP160101679A patent/AR104918A1/es unknown
- 2016-06-07 TW TW105118021A patent/TWI622591B/zh not_active IP Right Cessation
- 2016-06-16 EA EA201792308A patent/EA201792308A1/ru unknown
- 2016-06-16 EP EP16732192.6A patent/EP3310781A1/en not_active Withdrawn
- 2016-06-16 BR BR112017024613A patent/BR112017024613A2/pt not_active Application Discontinuation
- 2016-06-16 MX MX2017015837A patent/MX2017015837A/es unknown
- 2016-06-16 WO PCT/US2016/037832 patent/WO2016205487A1/en active Application Filing
- 2016-06-16 CR CR20170533A patent/CR20170533A/es unknown
- 2016-06-16 AU AU2016280815A patent/AU2016280815A1/en not_active Abandoned
- 2016-06-16 US US15/579,612 patent/US20180134713A1/en not_active Abandoned
- 2016-06-16 PE PE2017002470A patent/PE20180504A1/es unknown
- 2016-06-16 CN CN201680032170.5A patent/CN107660206A/zh active Pending
- 2016-06-16 MA MA045901A patent/MA45901A/fr unknown
- 2016-06-16 CA CA2984627A patent/CA2984627A1/en not_active Abandoned
- 2016-06-16 TN TNP/2017/000530A patent/TN2017000530A1/en unknown
- 2016-06-16 NZ NZ736999A patent/NZ736999A/en not_active IP Right Cessation
- 2016-06-16 JP JP2017564727A patent/JP2018519280A/ja active Pending
- 2016-06-16 KR KR1020177036019A patent/KR20180008637A/ko active Search and Examination
-
2017
- 2017-11-01 IL IL255386A patent/IL255386A0/en unknown
- 2017-12-05 CL CL2017003112A patent/CL2017003112A1/es unknown
- 2017-12-11 SV SV2017005586A patent/SV2017005586A/es unknown
- 2017-12-18 DO DO2017000300A patent/DOP2017000300A/es unknown
- 2017-12-19 PH PH12017502360A patent/PH12017502360A1/en unknown
- 2017-12-19 EC ECIEPI201783426A patent/ECSP17083426A/es unknown
- 2017-12-21 CO CONC2017/0013226A patent/CO2017013226A2/es unknown
-
2018
- 2018-06-28 HK HK18108312.4A patent/HK1248699A1/zh unknown
- 2018-10-25 US US16/170,137 patent/US20190062337A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ECSP17083426A (es) | 2018-02-28 |
WO2016205487A1 (en) | 2016-12-22 |
US20190062337A1 (en) | 2019-02-28 |
EA201792308A1 (ru) | 2018-05-31 |
DOP2017000300A (es) | 2018-01-31 |
MX2017015837A (es) | 2018-04-10 |
PE20180504A1 (es) | 2018-03-09 |
MA45901A (fr) | 2019-06-19 |
EP3310781A1 (en) | 2018-04-25 |
PH12017502360A1 (en) | 2018-06-25 |
NZ736999A (en) | 2019-05-31 |
BR112017024613A2 (pt) | 2018-07-31 |
CO2017013226A2 (es) | 2018-03-28 |
AR104918A1 (es) | 2017-08-23 |
HK1248699A1 (zh) | 2018-10-19 |
CR20170533A (es) | 2018-01-25 |
TWI622591B (zh) | 2018-05-01 |
AU2016280815A1 (en) | 2017-11-23 |
TN2017000530A1 (en) | 2019-04-12 |
KR20180008637A (ko) | 2018-01-24 |
CL2017003112A1 (es) | 2018-06-01 |
TW201712015A (zh) | 2017-04-01 |
CA2984627A1 (en) | 2016-12-22 |
IL255386A0 (en) | 2017-12-31 |
JP2018519280A (ja) | 2018-07-19 |
US20180134713A1 (en) | 2018-05-17 |
CN107660206A (zh) | 2018-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SV2017005586A (es) | Procesos e intermediarios para la preparacion de {1- (etilsulfonil) -3- [4 -(7h -pirrolo [2, 3-d] pirimidin -4- il) -1h -pirazol -1- il] azetidin -3- il} acetonitrilo | |
CL2016001871A1 (es) | Anticuerpos humanos para pd-1 | |
MA44702A (fr) | Compositions de suspension à libération prolongée | |
CL2016003145A1 (es) | Compuestos de [1,2,4]triazol sustituido | |
MA40774A (fr) | Dérivés de diaryle-urée en tant qu'inhibiteurs de kinase p38 | |
DK3474804T4 (da) | Medicinsk forbinding | |
DK3298027T3 (da) | Anthelmintiske depsipeptidforbindelser | |
MA41140A (fr) | Dérivés de 2,4-dioxo-quinazoline-6-sulfonamide en tant qu'inhibiteurs de la parg | |
DK3653599T3 (da) | Krystallinsk tapentadolphosphat | |
DK3244717T3 (da) | Jordbearbejdningsredskab | |
EP3218703A4 (en) | Determining the identity of modified compounds | |
GB2556654B (en) | Production of alkylated compounds | |
BR112016019246A2 (pt) | processo paraa fabricação de hidroclorofluoro-olefinas | |
ES2789757T8 (es) | Herramienta de conformado | |
ITUA20161990A1 (it) | Mangiatoia per avicoltura | |
ITBA20140018A1 (it) | Macchinario per la produzione di stracciatella | |
ITUA20161550A1 (it) | Procedimento per la produzione di RNA | |
DK3559403T3 (da) | Forbedret værktøj | |
IT201700050223A1 (it) | Procedimento per la preparazione di dexlansoprazolo cristallino | |
DE112017000878A5 (de) | Kupplungsgeberzylinder | |
EA201791596A1 (ru) | Пиразоловые соединения | |
ES1108955Y (es) | Horma para la personalizacion de calzados | |
ES1105180Y (es) | Insertos antivibración | |
ITUA20164040A1 (it) | Procedimento per la preparazione di polimorfo a | |
ITUB20161079A1 (it) | Procedimento per la preparazione di sofosbuvir |